183 related articles for article (PubMed ID: 31368912)
1. Carcinoma In Situ With Plasmacytoid Features: A Clinicopathologic Study of 23 Cases.
Sangoi AR; Falzarano SM; Nicolas M; McKenney JK
Am J Surg Pathol; 2019 Dec; 43(12):1638-1643. PubMed ID: 31368912
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical staining patterns of Ki-67 and p53 in florid reactive urothelial atypia and urothelial carcinoma in situ demonstrate significant overlap.
Nguyen JK; Przybycin CG; McKenney JK; Magi-Galluzzi C
Hum Pathol; 2020 Apr; 98():81-88. PubMed ID: 32142835
[TBL] [Abstract][Full Text] [Related]
3. Discriminatory immunohistochemical staining of urothelial carcinoma in situ and non-neoplastic urothelium: an analysis of cytokeratin 20, p53, and CD44 antigens.
McKenney JK; Desai S; Cohen C; Amin MB
Am J Surg Pathol; 2001 Aug; 25(8):1074-8. PubMed ID: 11474293
[TBL] [Abstract][Full Text] [Related]
4. Transition between urothelial carcinoma in situ and non-invasive micropapillary carcinoma as a pivot connection between diverse morphologies of bladder carcinoma: a case report of urothelial carcinoma with villoglandular differentiation.
Tajima S; Koda K
Int J Clin Exp Pathol; 2015; 8(3):3288-93. PubMed ID: 26045854
[TBL] [Abstract][Full Text] [Related]
5. Urothelial carcinoma in situ with "overriding" features can evade detection by mimicking umbrella cells.
Bahceci D; Nguyen JK; Sangoi AR; Stohr BA; Chan E
Hum Pathol; 2023 Jun; 136():56-62. PubMed ID: 36997033
[TBL] [Abstract][Full Text] [Related]
6. Plasmacytoid transitional cell carcinoma of urinary bladder: a clinicopathologic study of 9 cases.
Ro JY; Shen SS; Lee HI; Hong EK; Lee YH; Cho NH; Jung SJ; Choi YJ; Ayala AG
Am J Surg Pathol; 2008 May; 32(5):752-7. PubMed ID: 18379419
[TBL] [Abstract][Full Text] [Related]
7. Urothelial Carcinoma In Situ of the Bladder With Glandular Differentiation: Report of 92 Cases.
Yang Z; Epstein JI
Am J Surg Pathol; 2018 Jul; 42(7):971-976. PubMed ID: 29683821
[TBL] [Abstract][Full Text] [Related]
8. Noninvasive squamous lesions in the urinary bladder: a clinicopathologic analysis of 29 cases.
Guo CC; Fine SW; Epstein JI
Am J Surg Pathol; 2006 Jul; 30(7):883-91. PubMed ID: 16819332
[TBL] [Abstract][Full Text] [Related]
9. Intratumoral heterogeneity of surrogate molecular subtypes in urothelial carcinoma in situ of the urinary bladder: implications for prognostic stratification of high-risk non-muscle-invasive bladder cancer.
Garczyk S; Bischoff F; Schneider U; Golz R; von Rundstedt FC; Knüchel R; Degener S
Virchows Arch; 2021 Aug; 479(2):325-335. PubMed ID: 33650041
[TBL] [Abstract][Full Text] [Related]
10. Carcinoma in situ of the urinary bladder: review of clinicopathologic characteristics with an emphasis on aspects related to molecular diagnostic techniques and prognosis.
Nese N; Gupta R; Bui MH; Amin MB
J Natl Compr Canc Netw; 2009 Jan; 7(1):48-57. PubMed ID: 19176205
[TBL] [Abstract][Full Text] [Related]
11. Urothelial carcinoma of the bladder, lipid cell variant: clinicopathologic findings and LOH analysis.
Lopez-Beltran A; Amin MB; Oliveira PS; Montironi R; Algaba F; McKenney JK; de Torres I; Mazerolles C; Wang M; Cheng L
Am J Surg Pathol; 2010 Mar; 34(3):371-6. PubMed ID: 20139762
[TBL] [Abstract][Full Text] [Related]
12. Flat urothelial carcinoma in situ of the bladder with glandular differentiation.
Lopez-Beltran A; Jimenez RE; Montironi R; Patriarca C; Blanca A; Menendez CL; Algaba F; Cheng L
Hum Pathol; 2011 Nov; 42(11):1653-9. PubMed ID: 21531007
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of atypical papillary urothelial hyperplasia.
Swierczynski SL; Epstein JI
Hum Pathol; 2002 May; 33(5):512-7. PubMed ID: 12094376
[TBL] [Abstract][Full Text] [Related]
14. Utility of cytokeratin 5/6, cytokeratin 20, and p16 in the diagnosis of reactive urothelial atypia and noninvasive component of urothelial neoplasia.
Edgecombe A; Nguyen BN; Djordjevic B; Belanger EC; Mai KT
Appl Immunohistochem Mol Morphol; 2012 May; 20(3):264-71. PubMed ID: 22498670
[TBL] [Abstract][Full Text] [Related]
15. The pagetoid variant of bladder urothelial carcinoma in situ A clinicopathological study of 11 cases.
Lopez-Beltran A; Luque RJ; Moreno A; Bollito E; Carmona E; Montironi R
Virchows Arch; 2002 Aug; 441(2):148-53. PubMed ID: 12189504
[TBL] [Abstract][Full Text] [Related]
16. Flat Intraurothelial Neoplasia Exhibiting Diffuse Immunoreactivity for CD44 and Cytokeratin 5 (Urothelial Stem Cell/Basal Cell Markers): A Variant of Intraurothelial Neoplasia Commonly Associated With Muscle-invasive Urothelial Carcinoma.
Mai KT; Busca A; Belanger EC
Appl Immunohistochem Mol Morphol; 2017 Aug; 25(7):505-512. PubMed ID: 26990746
[TBL] [Abstract][Full Text] [Related]
17. [Plasmacytoid urothelial carcinoma of the urinary bladder: a clinicopathologic study of 16 cases].
Zhang W; Jiang YX; Liu Y; Yu WJ; Zhao H; Li YJ
Zhonghua Bing Li Xue Za Zhi; 2013 Jul; 42(7):433-7. PubMed ID: 24246859
[TBL] [Abstract][Full Text] [Related]
18. Urachal carcinoma: a clinicopathologic analysis of 24 cases with outcome correlation.
Gopalan A; Sharp DS; Fine SW; Tickoo SK; Herr HW; Reuter VE; Olgac S
Am J Surg Pathol; 2009 May; 33(5):659-68. PubMed ID: 19252435
[TBL] [Abstract][Full Text] [Related]
19. Morphologic expressions of urothelial carcinoma in situ: a detailed evaluation of its histologic patterns with emphasis on carcinoma in situ with microinvasion.
McKenney JK; Gomez JA; Desai S; Lee MW; Amin MB
Am J Surg Pathol; 2001 Mar; 25(3):356-62. PubMed ID: 11224606
[TBL] [Abstract][Full Text] [Related]
20. [Urothelial hyperplastic lesion with endophytic growth pattern: a clinicopathologic study].
Xiao L; Wang CF; Zhu XZ; Yin YL; Chen Y; Lu C; Yu B
Zhonghua Bing Li Xue Za Zhi; 2011 May; 40(5):319-23. PubMed ID: 21756826
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
